Human medicines European public assessment report (EPAR): Comtan, entacapone, Date of authorisation: 22/09/1998, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 11, Status: Authorised
The European Journal of Case Reports in Internal Medicine (EJCRIM) - official journal of EFIM entirely dedicated to case reports - is seeking an Assistant Editor to join its editorial team and to be part of the Editorial Board of the journal.
This role is an opportunity for an experienced internal medicine physician to help to shape the dissemination of high-quality clinical case reports.
Please note that this is a voluntary position and does not include any financial compensation honorarium.
Key Responsibilities:
Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation: 13/02/2020, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Truvelog Mix 30, insulin aspart, Date of authorisation: 25/04/2022, Revision: 3, Status: Withdrawn
EMEA-003192-PIP03-23
EMA/PE/0000230710
Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation: 13/02/2017, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Kerendia, finerenone, Date of authorisation: 16/02/2022, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 20, Status: Authorised